Schedule 13G ownership disclosure

NOVOCURE LTD ORD SHS

Common Stock · CUSIP: G6674U108

Event date: 2025-06-30

Filing-level shares
0.00
Percent of class
0.0%
  • Capital International Investors

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001562230-25-000087
Form type
SCHEDULE 13G/A
Filer
Capital International Investors
CIK
CIK 1562230
Filed
Jul 07, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub